Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $65.84M+32.0% | $49.87M+19.8% | $41.63M-12.2% | $47.4M+1.2% | $46.85M-17.2% | ||
| $32.14M-13.2% | $37.02M+2.9% | $35.98M-9.2% | $39.63M+1.3% | $39.13M+5.3% | ||
| $33.7M+162% | $12.84M+127% | $5.66M-27.2% | $7.77M+0.6% | $7.73M-60.2% | ||
| 51.2%+25.4pp | 25.8%+12.2pp | 13.6%-2.8pp | 16.4%-0.1pp | 16.5%-17.8pp | ||
| $3.89M+2.7% | $3.79M-1.5% | $3.84M-21.3% | $4.88M-0.1% | $4.89M+7.2% | ||
| $29.09M-7.9% | $31.58M-10.8% | $35.4M-8.2% | $38.58M-2.5% | $39.56M-4.1% | ||
| $35.86M-49.9% | $71.64M+53.4% | $46.69M-58.9% | $113.68M+99.8% | $56.89M-0.4% | ||
| -$2.16M+96.3% | -$58.8M-43.3% | -$41.03M+38.1% | -$66.28M-34.8% | -$49.16M-30.4% | ||
| -3.3%+115pp | -117.9%-19.3pp | -98.6%+41.3pp | -139.8%-34.9pp | -104.9%-38.3pp | ||
| $5.75M-12.3% | $6.56M-4.2% | $6.84M+0.4% | $6.82M+0.5% | $6.78M-39.8% | ||
| -$494K-1,049% | -$43K+39.4% | -$71K+98.3% | -$4.06M-17,025% | $24K— | ||
| -$6.53M+89.6% | -$63.01M-39.6% | -$45.15M+39.1% | -$74.13M-40.7% | -$52.69M-14.4% | ||
| -$151K— | $0+100% | -$92K+97.9% | -$4.29M-2,747% | $162K+2,414% | ||
| -$3.73M+89.5% | -$35.68M-39.6% | -$25.56M+35.4% | -$39.59M-32.2% | -$29.95M-15.6% | ||
| -5.7%+65.9pp | -71.6%-10.2pp | -61.4%+22.1pp | -83.5%-19.6pp | -63.9%-18.1pp | ||
| -$0.02+91.7% | -$0.24-33.3% | -$0.18+33.3% | -$0.27-28.6% | -$0.21-16.7% | ||
| $9.21M+120% | -$46.35M-66.4% | -$27.85M+47.6% | -$53.12M-45.8% | -$36.44M-43.8% | ||
| 14%+107pp | -92.9%-26.1pp | -66.9%+45.2pp | -112.1%-34.3pp | -77.8%-33.0pp | ||
| -$2.16M+96.3% | -$58.8M-43.3% | -$41.03M+38.1% | -$66.28M-34.8% | -$49.16M-30.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $204.7M in revenue over the trailing twelve months, down 15.3% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $104.6M over the trailing twelve months, a -51.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 29.3% and operating margin is -82.2%, with a -51.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.71.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
